Vadodara, India

Sunit Kumar

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2018.


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:

goldMedal1 out of 834,453 
Other
 patents

Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sunit Kumar: Innovator in Pharmaceutical Chemistry

Introduction

Sunit Kumar is a notable inventor based in Vadodara, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel drug forms. His work focuses on enhancing the efficacy and stability of pharmaceutical compounds.

Latest Patents

Sunit Kumar holds a patent for "Polymorphic forms of vortioxetine and its pharmaceutically acceptable salts." This invention provides polymorphic forms of vortioxetine and its pharmaceutically acceptable salts. Specifically, it relates to novel crystalline forms of vortioxetine or its pharmaceutically acceptable salts. Moreover, the invention also includes an amorphous form of vortioxetine hydrobromide and a stable amorphous co-precipitate of vortioxetine hydrobromide with pharmaceutically acceptable excipients. He has 1 patent to his name.

Career Highlights

Throughout his career, Sunit Kumar has demonstrated a commitment to advancing pharmaceutical science. His innovative approaches have contributed to the development of more effective medications. His work is recognized for its potential impact on patient care and treatment outcomes.

Collaborations

Sunit Kumar has collaborated with notable professionals in his field, including Venkat Raman Jayaraman and Sanjiv Tomer. These collaborations have fostered a productive environment for research and innovation.

Conclusion

Sunit Kumar is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in drug formulation. His contributions continue to influence the industry and improve therapeutic options for patients.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…